Abstract
BackgroundZoledronic acid is a bisphosphonate indicated for the prevention of skeletal-related events in patients with advanced malignancies involving bone and treatment of hypercalcaemia of malignancy. According to data sheet Zometa...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have